-
A Conceptual Paper on Integrating a Pharmacometric Multistate Model With Cost-Effectiveness Analysis for Infectious Diseases Treatment Optimization
Sep 9, 2025, 16:22 PM -
Resource Utilization Among Patients With Epidermolysis Bullosa: Preliminary Findings From Seven European Countries
Sep 9, 2025, 16:22 PM -
Quantifying the Societal Burden of Acanthamoeba Keratitis: Results From a Patient Survey
Sep 9, 2025, 16:22 PM -
Inter-Version Comparison of the Boston Carpal Tunnel Questionnaire: A Clinical Validation Study of the Decision Tree-Based Version
Sep 9, 2025, 16:22 PM -
Validation Between Antidepressant Treatment Failure Proxy and PHQ-9 Score in Major Depressive Disorder Using a Linked Insurance Claims and Electronic Health Record Dataset
Sep 9, 2025, 16:22 PM -
What Are the Impacts of the Absence of Health Economic Evaluations for Drugs Granted an ASMR IV Rating by the French National Authority of Health (HAS)? An Analysis of Medicines Assessed Between May 2022 and May 2024
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness of I-CREATE: An Inpatient Intrinsic Capacity Risk Evaluation Towards Holistic Assessment and Targeted Management of Elderly in Acute Care
Sep 9, 2025, 16:22 PM -
Challenges in PICO Definition for HTDs: Lessons From Durvalumab Exercise
Sep 9, 2025, 16:22 PM -
Healthcare Resource Use and Direct Healthcare Costs Associated With Respiratory Syncytial Virus Infections in Individuals Aged 18 Years or Older in Italy: A Retrospective Observational Study
Sep 9, 2025, 16:22 PM -
Cost Utility Analysis of a Digital Peer Navigation Program for Men With Prostate Cancer
Sep 9, 2025, 16:22 PM -
To Be or Not to Be Willing to Pay
Sep 9, 2025, 16:22 PM -
Economic Evaluation of Atogepant vs. Placebo for the Preventive Treatment of Episodic Migraine in Taiwan
Sep 9, 2025, 16:22 PM -
Italian Perspective on Rare Disease New Treatments and HTA: Insights From Iptacopan Multidimensional Evaluation in PNH
Sep 9, 2025, 16:22 PM -
Network Meta-Analysis NMA of Clinical Effectiveness of Second-Line (2L+) Treatments in Extensive-Stage Small Cell Lung Cancer (ES-SCLC)
Sep 9, 2025, 16:22 PM -
Systemic Solutions Influencing Physicians' Prescription Behavior Leading to Savings in the Reimbursement Budget in European Countries: A Systematic Literature Review
Sep 9, 2025, 16:22 PM -
Cost Comparison of Alternative Delivery Routes for Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RA) in the English National Health Service (NHS)
Sep 9, 2025, 16:22 PM -
German Early Benefit Assessments and the Impact of Medical Societies: An Analysis
Sep 9, 2025, 16:22 PM -
Navigating Uncharted Waters: Challenge of Anticipating Technologies Subject to Environmental Considerations in Future HTA
Sep 9, 2025, 16:22 PM -
Exploring the Impact of Patient Characteristics and Reporting Period on Adverse Drug Withdrawal Event Signals in the FAERS Database: A Stratified Disproportionality Analysis Study
Sep 9, 2025, 16:22 PM -
The Next Steps Matter? New Cancer Medicines and Their Indication Extensions in Europe 2010-2020
Sep 9, 2025, 16:22 PM
